Transforming growth factor-Β decreases the cancer-initiating cell population within diffuse-type gastric carcinoma cells

Oncogene

Volumn 30, Issue 14, 2011, Pages 1693-1705

  Ehata, S ^a,b   Johansson, E ^a   Katayama, R ^b   Koike, S ^b   Watanabe, A ^c   Hoshino, Y ^a   Katsuno, Y ^a   Komuro, A ^a   Koinuma, D ^a   Kano, M R ^a   Yashiro, M ^d   Hirakawa, K ^d   Aburatani, H ^c   Fujita, N ^b   Miyazono, K ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b CANCER CHEMOTHERAPY CENTER   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

^d OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

ABCG2; cancer initiating cell; diffuse type gastric carcinoma; SP cell; TGF

Indexed keywords

BREAST CANCER RESISTANCE PROTEIN; SMAD2 PROTEIN; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL; CARCINOGENESIS; CARCINOGENICITY; CELL POPULATION; GENE SILENCING; HUMAN; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIDE POPULATION CELL; STOMACH CARCINOMA; TRANSCRIPTION REGULATION;

ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; CARCINOMA; CELL LINE, TUMOR; DISEASE PROGRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LYMPHATIC METASTASIS; MICE; NEOPLASM PROTEINS; NEOPLASTIC STEM CELLS; PROMOTER REGIONS, GENETIC; SIDE-POPULATION CELLS; SMAD2 PROTEIN; SMAD3 PROTEIN; STOMACH NEOPLASMS; TRANSFORMING GROWTH FACTOR BETA; TRANSPLANTATION, HETEROLOGOUS;

EID: 79953788906     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2010.546     Document Type: Article

References (55)

1. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF. (2003). Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 100: 3983-3988. (Pubitemid 36418143)
2. Bierie B, Moses HL. (2006). Tumour microenvironment: TGF-b: the molecular Jekyll and Hyde of cancer. Nat Rev Cancer 6: 506-520. (Pubitemid 43980540)
3. Bonnet D, Dick JE. (1997). Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hemato-poietic cell. Nat Med 3: 730-737. (Pubitemid 27298715)
4. Crew KD, Neugut AI. (2006). Epidemiology of gastric cancer. World J Gastroenterol 12: 354-362. (Pubitemid 43329250)
5. Dean M, Fojo T, Bates S. (2005). Tumor stem cells and drug resistance. Nat Rev Cancer 5: 275-284. (Pubitemid 40488633)
6. Dennis Jr G, Sherman BT, Hosack DA, Yang J, Gao W, Lane HC et al. (2003). DAVID: database for annotation, visualization, and integrated discovery. Genome Biol 4: 3.
7. Derynck R, Zhang YE. (2003). Smad-dependent and Smad-indepen-dent pathways in TGF-b family signalling. Nature 425: 577-584. (Pubitemid 37280136)
8. Ehata S, Hanyu A, Fujime M, Katsuno Y, Fukunaga E, Goto K et al. (2007a). Ki26894, a novel transforming growth factor-b type I receptor kinase inhibitor, inhibits in vitro invasion and in vivo bone metastasis of a human breast cancer cell line. Cancer Sci 98: 127-133. (Pubitemid 44803931)
9. Ehata S, Hanyu A, Hayashi M, Aburatani H, Kato Y, Fujime M et al. (2007b). Transforming growth factor-b promotes survival of mammary carcinoma cells through induction of antiapoptotic transcription factor DEC1. Cancer Res 67: 9694-9703. (Pubitemid 47621216)
10. Fujihara T, Sawada T, Hirakawa K, Chung YS, Yashiro M, Inoue T et al. (1998). Establishment of lymph node metastatic model for human gastric cancer in nude mice and analysis of factors associated with metastasis. Clin Exp Metastasis 16: 389-398. (Pubitemid 28255534)
11. Goodell MA, Rosenzweig M, Kim H, Marks DF, DeMaria M, Paradis G et al. (1997). Dye efflux studies suggest that hematopoie-tic stem cells expressing low or undetectable levels of CD34 antigen exist in multiple species. Nat Med 3: 1337-1345. (Pubitemid 28011033)
12. Gradhand U, Kim RB. (2008). Pharmacogenomics of MRP transporters (ABCC1-5) and BCRP (ABCG2). Drug Metab Rev 40: 317-354. (Pubitemid 352000949)
13. Grady WM, Markowitz SD. (2008) Derynck R, Miyazono K (ed). The TGF-b Family. Cold Spring Harbor Laboratory Press: USA, pp 889-937.
14. Hahn SA, Schutte M, Hoque AT, Moskaluk CA, da Costa LT, Rozenblum E et al. (1996). DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science 271: 350-353.
15. Hermann PC, Huber SL, Herrler T, Aicher A, Ellwart JW, Guba M et al. (2007). Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell 1: 313-323. (Pubitemid 47355323)
16. Hohenberger P, Gretschel S. (2003). Gastric cancer. Lancet 362: 305-315. (Pubitemid 36936845)
17. Inoue T, Chung YS, Yashiro M, Nishimura S, Hasuma T, Otani S et al. (1997). Transforming growth factor-b and hepatocyte growth factor produced by gastric fibroblasts stimulate the invasiveness of scirrhous gastric cancer cells. Jpn J Cancer Res 88: 152-159. (Pubitemid 27129642)
18. Ikushima H, Todo T, Ino Y, Takahashi M, Miyazawa K, Miyazono K. (2009). Autocrine TGF-b signaling maintains tumorigenicity of glioma-initiating cells through Sry-related HMG-boxfactors. Cell Stem Cell 5: 504-514.
19. Iwasaki H, Suda T. (2009). Cancer stem cells and their niche. Cancer Sci 100: 1166-1172.
20. Katayama R, Koike S, Sato S, Sugimoto Y, Tsuruo T, Fujita N. (2009). Dofequidar fumarate sensitizes cancer stem-like side population cells to chemotherapeutic drugs by inhibiting ABCG2/ BCRP-mediated drug export. Cancer Sci 100: 2060-2068.
21. Kinugasa S, Abe S, Tachibana M, Hishikawa Y, Yoshimura H, Monden N et al. (1998). Overexpression of transforming growth factor-b1 in scirrhous carcinoma of the stomach correlates with decreased survival. Oncology 55: 582-587. (Pubitemid 28479119)
22. Kiyono K, Suzuki HI, Morishita Y, Komuro A, Iwata C, Yashiro M et al. (2009). c-Ski overexpression promotes tumor growth and angiogenesis through inhibition of transforming growth factor-b signaling in diffuse-type gastric carcinoma. Cancer Sci 100: 1809-1816.
23. Koinuma D, Tsutsumi S, Kamimura N, Taniguchi H, Miyazawa K, Sunamura M et al. (2009). Chromatin immunoprecipitation on microarray analysis of Smad2/3 binding sites reveals roles of ETS1 and TFAP2A in transforming growth factor b signaling. Mol Cell Biol 291: 172-186.
24. Komuro A, Yashiro M, Iwata C, Morishita Y, Johansson E, Matsumoto Y et al. (2009). Diffuse-type gastric carcinoma: progression, angiogenesis, and transforming growth factor b signaling. J Natl Cancer Inst 101: 592-604.
25. Laboisse CL, Augeron C, Potet F. (1981). Growth and differentiation of human gastrointestinal adenocarcinoma stem cells in soft agarose. Cancer Res 41: 310-315. (Pubitemid 11218835)
26. Lee J, Son MJ, Woolard K, Donin NM, Donin NM, Li A et al. (2008). Epigenetic-mediated dysfunction of the bone morphogenetic protein pathway inhibits differentiation of glioblastoma-initiating cells. Cancer Cell 13: 69-80. (Pubitemid 350309742)
27. Lobo NA, Shimono Y, Qian D, Clarke MF. (2007). The biology of cancer stem cells. Annu Rev Cell Dev Biol 23: 675-699.
28. Markowitz S, Roberts A. (1996). Tumor suppressor activity of the TGF-b pathway in human cancers. Cytokine Growth Factor Rev 7: 93-102. (Pubitemid 27202668)
29. Massague J. (2008). TGF-b in Cancer. Cell 134: 215-230.
30. Mishra L, Shetty K, Tang Y, Stuart A, Byers SW. (2005). The role of TGF-P and Wnt signaling in gastrointestinal stem cells and cancer. Oncogene 24: 5775-5789. (Pubitemid 43086137)
31. Miyazawa K, Shinozaki M, Hara T, Furuya T, Miyazono K. (2002). Two major Smad pathways in TGF-P superfamily signalling. Genes Cells 7: 1191-1204. (Pubitemid 36024597)
32. Mizoi T, Ohtani H, Miyazono K, Miyazawa M, Matsuno S, Nagura H. (1993). Immunoelectron microscopic localization of transforming growth factor p1 and latent transforming growth factor p1 binding protein in human gastrointestinal carcinomas: qualitative difference between cancer cells and stromal cells. Cancer Res 53: 183-190. (Pubitemid 23019396)
33. Naka K, Hoshii T, Muraguchi T, Tadokoro Y, Ooshio T, Kondo Y et al. (2010). TGF-P-FOXO signalling maintains leukaemia-initiating cells in chronic myeloid leukaemia. Nature 463: 676-680.
34. Nishii T, Yashiro M, Shinto O, Sawada T, Ohira M, Hirakawa K. (2009). Cancer stem cell-like SP cells have a high adhesion ability to the peritoneum in gastric carcinoma. Cancer Sci 100: 1397-1402.
35. Patrawala L, Calhoun T, Schneider-Broussard R, Zhou J, Claypool K, Tang DG (2005). Side population is enriched in tumorigenic, stemlike cancer cells, whereas ABCG2+ and ABCG2- cancer cells are similarly tumorigenic. Cancer Res 65: 6207-6219. (Pubitemid 40994406)
36. Penuelas S, Anido J, Prieto-Sanchez RM, Folch G, Barba I, Cuartas I et al. (2009). TGF-P increases glioma-initiating cell self-renewal through the induction of LIF in human glioblastoma. Cancer Cell 15: 315-327.
37. Piccirillo SG, Reynolds BA, Zanetti N, Lamorte G, Binda E, Broggi G et al. (2006). Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells. Nature 444: 761-765. (Pubitemid 44949605)
38. Rabindran SK, Ross DD, Doyle LA, Yang W, Greenberger LM. (2000). Fumitremorgin C reverses multidrug resistance in cells transfected with the breast cancer resistance protein. Cancer Res 60: 47-50. (Pubitemid 30058728)
39. Scharenberg CW, Harkey MA, Torok-Storb B. (2002). The ABCG2 transporter is an efficient Hoechst 33342 efflux pump and is preferentially expressed by immature human hematopoietic progenitors. Blood 99: 507-512. (Pubitemid 34533085)
40. Sneddon JB, Zhen HH, Montgomery K, van de Rijn M, Tward AD, West R et al. (2006). Bone morphogenetic protein antagonist gremlin 1 is widely expressed by cancer-associated stromal cells and can promote tumor cell proliferation. Proc Natl Acad Sci USA 103: 14842-14847. (Pubitemid 44527816)
41. Stingl J, Caldas C. (2007). Molecular heterogeneity of breast carcinomas and the cancer stem cell hypothesis. Nat Rev Cancer 7: 791-799. (Pubitemid 47463670)
42. Takaishi S, Okumura T, Tu S, Wang SS, Shibata W, Vigneshwaran R et al. (2009). Identification of gastric cancer stem cells using the cell surface marker CD44. Stem Cells 27: 1006-1020.
43. Takemura S, Yashiro M, Sunami T, Tendo M, Hirakawa K. (2004). Novel models for human scirrhous gastric carcinoma in vivo. Cancer Sci 95: 893-900. (Pubitemid 40045524)
44. Vagenas K, Spyropoulos C, Gavala V, Tsamandas AC. (2007). TGFb1, TGFb2, and TGFb3 protein expression in gastric carcinomas: correlation with prognostics factors and patient survival. J Surg Res 139: 182-188. (Pubitemid 46551168)
45. Velamakanni S, Wei SL, Janvilisri T, van Veen HW. (2007). ABCG transporters: structure, substrate specificities and physiological roles: a brief overview. J Bioenerg Biomembr 39: 465-471.
46. Visvader JE, Lindeman GJ. (2008). Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat Rev Cancer 8: 755-768.
47. Wakefield LM, Roberts AB. (2002). TGF-b signaling: positive and negative effects on tumorigenesis. Curr Opin Genet Dev 12: 22-29. (Pubitemid 34094985)
48. Weinberg RA. (1995). The retinoblastoma protein and cell cycle control. Cell 81: 323-330.
49. Wu C, Alman BA. (2008). Side population cells in human cancers. Cancer Lett 268: 1-9.
50. Yanagihara K, Kamada N, Tsumuraya M, Amano F. (1993). Establishment and characterization of a human gastric scirrhous carcinoma cell line in serum-free chemically defined medium. Int J Cancer 54: 200-207. (Pubitemid 23154882)
51. Yashiro M, Chung YS, Sowa M. (1994). Role of orthotopic fibroblasts in the development of scirrhous gastric carcinoma. Jpn J Cancer Res 85: 883-886. (Pubitemid 24294744)
52. Yashiro M, Chung YS, Nishimura S, Inoue T, Sowa M. (1996). Peritoneal metastatic model for human scirrhous gastric carcinoma in nude mice. Clin Exp Metastasis 14: 43-54. (Pubitemid 26008959)
53. Yashiro M, Yasuda K, Nishii T, Kaizaki R, Sawada T, Ohira M et al. (2009). Epigenetic regulation of the embryonic oncogene ERas in gastric cancer cells. Int J Oncol 35: 997-1003.
54. Yin L, Castagnino P, Assoian RK. (2008). ABCG2 expression and side population abundance regulated by a transforming growth factor b-directed epithelial-mesenchymal transition. Cancer Res 68: 800-807. (Pubitemid 351206757)
55. Zhou S, Schuetz JD, Bunting KD, Colapietro AM, Sampath J, Morris JJ et al. (2001). The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype. Nat Med 7: 1028-1034. (Pubitemid 32937383)